Autres langues Calidi Biotherapeutics, Inc.

Actions

CLDI

US3207031010

Marché Fermé - Nyse Autres places de cotation 22:00:00 06/05/2024			Varia. 5j.	Varia. 1 janv.
0,21 ^USD	+6,60%		+0,96%	-86,09%

21/03	CALIDI BIOTHERAPEUTICS, INC. : Opinion positive de HC Wainwright	ZM
07/02	Mise à jour sectorielle : Les actions du secteur de la santé plus fermes en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	01/05
Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24	24/04
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	23/04
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	19/04
Calidi Biotherapeutics Prices $6.1 Million Offering	16/04
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	16/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024	10/04
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024	09/04
Calidi Biotherapeutics, Inc. announced that it has received $3.5 million in funding	21/03
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results	15/03
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer	11/03
Calidi Biotherapeutics, Inc. announced that it expects to receive $3.5 million in funding	08/03
Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference	12/02
Sector Update: Health Care Stocks Firmer Late Afternoon	07/02
Calidi Biotherapeutics to Sell Common Stock	07/02
Calidi Biotherapeutics, Inc. announced that it has received $1 million in funding	26/01
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board	08/01
Calidi Biotherapeutics, Inc. Announces Scientific and Medical Advisory Board Appointments	08/01
Calidi Biotherapeutics, Inc.(NYSEAM:CLDI) added to S&P TMI Index	18/12
Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPre to its Board of Directors	13/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Calidi Biotherapeutics, Inc.

Actions

CLDI

US3207031010

Autres langues

Filtres